Comparative effectiveness research in chronic obstructive pulmonary disease

Journal of Comparative Effectiveness Research

Volumn 1, Issue 1, 2012, Pages 71-82

  Mularski, Richard A ^a   McBurnie, Mary Ann ^a   Lindenauer, Peter K ^b   Lee, Todd A ^c   Vollmer, William M ^a   Au, David H ^d   Carson, Shannon S ^e   Krishnan, Jerry A ^c  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b BAYSTATE HEALTH   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

chronic obstructive pulmonary disease; comparative effectiveness research; data warehouse; emphysema; health services research; outcome research; quasi experimental design; registry; translational research

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE; STEROID;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMPARATIVE EFFECTIVENESS; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH SERVICES RESEARCH; HUMAN; INFORMATION DISSEMINATION; LOW DRUG DOSE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; OBSERVATIONAL STUDY; PATIENT CARE; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH PRIORITY; REVIEW; STUDY DESIGN; TRANSLATIONAL RESEARCH; UNSPECIFIED SIDE EFFECT;

EID: 84886945216     PISSN: 20426305     EISSN: 20426313     Source Type: Journal    
DOI: 10.2217/cer.11.10     Document Type: Review

References (39)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR Surveill. Summ. 51(6), 1-16 (2002).
2. Medicare Payment Advisory Commission. Report to the Congress: Promoting Greater Efficiency in Medicare. MEDPAC, Washington, DC, USA (2007).
3. Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD 7(3), 214-228 (2010).
4. Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 144(12), 894-903 (2006).
5. Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J. Assessment of the economic burden of COPD in the US: a review and synthesis of the literature. COPD 3(4), 211-218 (2006).
6. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 23(6), 932-946 (2004).
7. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176(6), 532-555 (2007).
8. National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 59(Suppl. 1), 1-232 (2004).
9. Calverley PM, Anderson JA, Celli B et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 356(8), 775-789 (2007).
10. Tashkin DP, Celli B, Senn S et al. A 4 year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 359(15), 1543-1554 (2008).
11. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA 303(23), 2359-2367 (2010).
12. Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA 303(20), 2035-2042 (2010).
13. Mularski RA, Asch SM, Shrank WH et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest 130(6), 1844-1850 (2006).
14. Bratzler DW, Oehlert WH, McAdams LM, Leon J, Jiang H, Piatt D. Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: physician practices in the community hospital setting. J. Okla. State Med. Assoc. 97(6), 227-232 (2004).
15. Heffner JE, Mularski RA, Calverley PM. COPD performance measures: missing opportunities for improving care. Chest 137(5), 1181-1189 (2010).
16. Institute of Medicine. Initial National Priorities For Comparative Effectiveness Research. National Academies Press, Washington, DC, USA (2009).
17. Federal Coordinating Counsel for Comparative Effectiveness Research. Report to the President and Congress. Department of Health and Human Services, Washington, DC, USA, 1-73 (2009).
18. Lieu TA, Au D, Krishnan JA et al.; The Comparative Effectiveness Research in Lung Diseases Workshop Panel. Comparative effectiveness research in lung diseases and sleep disorders: recommendations from the national heart, lung and blood institute workshop. Am. J. Respir. Crit. Care Med. 184, 848-856 (2011).
19. Iglehart JK. Prioritizing comparative-effectiveness research - IOM recommendations. N. Engl. J. Med. 361(4), 325-328 (2009).
20. Lauer MS, Collins FS. Using science to improve the nation's health system: NIH's commitment to comparative effectiveness research. JAMA 303(21), 2182-2183 (2010).
21. Clancy C, Collins FS. Patient-Centered Outcomes Research Institute: the intersection of science and healthcare. Sci. Transl. Med. 2(37), 37cm18 (2010).
22. Selker HP, Strom BL, Ford DE et al. White paper on CTSA consortium role in facilitating comparative effectiveness research: September 23, 2009 CTSA consortium strategic goal committee on comparative effectiveness research. Clin. Transl. Sci. 3(1), 29-37 (2010).
23. Dougherty D, Conway PH. The '3T's' road map to transform US healthcare: the 'how' of high-quality care. JAMA 299(19), 2319-2321 (2008).
24. Kahn JM, Scales DC, Au DH et al. An official American Thoracic Society policy statement: pay-for-performance in pulmonary, critical care, and sleep medicine. Am. J. Respir. Crit. Care Med. 181(7), 752-761 (2010).
25. Krishnan JA, Mularski RA. Acting on comparative effectiveness research in COPD. JAMA 303(23), 2409-2410 (2010).
26. Shadish WR, Cook TD, Campbell DT. Experimental and Quasi-experimental Designs for Generalized Causal Inference. Houghton- Mifflin, Boston, MA, USA (2002).
27. Mark MM, Rechardt CS. Quasi-experimental and correlational designs: methods for the real world when random assignment isn't feasible. In: Handbook of Methods in Social Psychology. Sansone C, Morf CC, Panter AT (Eds). Sage Publications, Thousand Oaks, CA, USA, 265-286 (2004).
28. Mercer SL, DeVinney BJ, Fine LJ, Green LW, Dougherty D. Study designs for effectiveness and translation research: identifying trade-offs. Am. J. Prev. Med. 33(2), 139-154 (2007).
29. Rubin DB. Assignment to treatment group on the basis of a covariate. J. Educat. Stat. 2, 1-26 (1977).
30. Biglan A, Ary D, Wagenaar AC. The value of interrupted time-series experiments for community intervention research. Prev. Sci. 1(1), 31-49 (2000).
31. West SG, Biesanz JC, Pitts SC. Causal inference and generalization in field settings: experimental and quasi-experimental designs. In: Handbook of Research Methods in Social and Personality Psychology. Reis HT, Judd CM (Eds). Cambridge University Press, NY, USA, 40-84 (2000).
32. Hawkins NG, Sanson-Fisher RW, Shakeshaft A, D'Este C, Green LW. The multiple baseline design for evaluating population-based research. Am. J. Prev. Med. 33(2), 162-168 (2007).
33. Niewoehner DE, Erbland ML, Deupree RH et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N. Engl. J. Med. 340(25), 1941-1947 (1999).
34. Murphy MK, Black NA, Lamping DL et al. Consensus development methods, and their use in clinical guideline development. Health Technol. Assess. 2(3), i-iv, 1-88 (1998).
35. Vaidya OS, Kumar S. Analytic hierarchy process. Eur. J. Oper. Res. 169(1), 1-29 (2006).
36. Saaty TL. Relative measurement and its generalization in decision making. Why pairwise comparisons are central in mathematics for the measurement of intangible factors. The analytic hierarchy/network process. Rev. R. Acad. Cien. Serie A. Mat. 102(2), 251-318 (2008).
37. Saaty TL. Decision making with the analytic hierarchy process. Int. J. Serv. Sci. 1(1), 83-98 (2008).
38. Mularski RA, McBurnie MA, Lindenauer PK et al. Establishment of an integrated clinical network and comprehensive data warehouse for the conduct of comparative effectiveness research in COPD. Presented at: European Respiratory Society Annual Congress. Amsterdam, The Netherlands, 24-28 September 2011 (Abstract 4871).
39. Lewis S, Krishnan JA, Au DH et al. Novel multi-institutional data infrastructure for comparative effectiveness research in COPD (COPD DataHub). Am. J. Resp. Crit. Care Med. 183, A6437 (2011).